top of page
GLD Partners, LP Acquires Seelos Therapeutics, Inc. Assets, Strengthening GLD’s Growing Life Sciences Portfolio
GLD Partners, LP Acquires Seelos Therapeutics, Inc. Assets, Strengthening GLD’s Growing Life Sciences Portfolio
GLD Partners LP Launches New Biotech Company, Altagenics, to Accelerate Drug Discovery for Muscle-Wasting Diseases
In collaboration with Heligenics GigaAssay™ platform, the companies will speed the development of new therapies in aging-related diseases.
Daniel Gordon: After PPP, It is Time to Reconsider TPP
Missing from the recent discussion about economic rebirth has been an open and honest debate as to the importance of international trade.
GLD Partners, LP Forms Investment Fund to Focus on Urban Renewal Opportunities
Fund Aims to Acquire and Redevelop 10,000 Multi Family units in Urban Renewal Areas by 2025.
Why the Next Stimulus Package Needs a Prescription for Medical Debt Disease
Read the full post here: https://finance.yahoo.com/news/why-next-stimulus-package-needs-133834289.html By Daniel Gordon, Managing...
GLD Partners, LP to Donate Medical Supplies to Support COVID-19 Treatment Efforts
GLD Partners, LP announced that it will direct its factories based outside of the US to produce medical equipment in response to COVID-19.
bottom of page